Submission Details
| 510(k) Number | K233801 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 29, 2023 |
| Decision Date | August 23, 2024 |
| Days to Decision | 268 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
K233801 is an FDA 510(k) clearance for the Nalu Neurostimulation System for Spinal Cord Stimulation; Nalu Neurostimulation System for Peripheral Nerve Stimulation, a Stimulator, Spinal-cord, Implanted (pain Relief) (Class II — Special Controls, product code GZB), submitted by Boston Scientific Neuromodulation (Valencia, US). The FDA issued a Cleared decision on August 23, 2024, 268 days after receiving the submission on November 29, 2023. This device falls under the Neurology review panel. Regulated under 21 CFR 882.5880.
| 510(k) Number | K233801 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 29, 2023 |
| Decision Date | August 23, 2024 |
| Days to Decision | 268 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
| Product Code | GZB — Stimulator, Spinal-cord, Implanted (pain Relief) |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 882.5880 |